|
Editorial:
Do words have power?
Apparently, while in conversation with someone, whether, a friend, family or foe, the words we use have less impact on the outcome or intention of the conversation than tone of voice or body language.
One study felt words only amount to 7% of the conversation, whereas the tone of voice, 38% and body language, 55%!
I believe we are ‘wired’ to listen for ‘tone’ and view ‘body language’ to know whether to overall trust in the words being spoken. Our mind/feelings wander while a person speaks, as we see what they wear, how they smell, are they upset, bored, enthusiastic, or such.
I learned to hear the tone of my mom’s voice, or see her posture, to know whether she was in a good mood, or not!
In business or life in general, remember your tone and body language speak louder than your words!
Some highlights:
Trusted yet corrupt – Health Canada and Pharma own/control/enforce, the narrative for ‘proper medical treatment’ yet they continue to cause serious harm as this week’s FRN covers - from brain damage chemicals to statins increase in diabetes, to a mission to create sickness not a cure, and a10,000 increase in mark up for Pfizer in 2023. [I recall a 5% price increase would cause a fuss!]
Diesel Shortage – FRN does not have reporters in the field, to determine whether the ‘predicted’ diesel shortage will happen or not, however, if you are part of the supply chain, good to be in the know.
Happy Sales
dp
|
|
Quote of the Day
“Health experts say that daylight savings can cause more harm than good, disrupting our circadian rhythm and even increasing the likelihood of traffic accidents and heart attacks. Petition starter Irene believes Canada should abolish daylight savings time — add your support by signing today.” www.change.org
|
|
“Bayer Ordered to Pay $275 Million for Brain Damage Caused by Monsanto’s PCBs, But Chemical Giant Vows to Appeal –
“both companies have similar shareholders, who also are heavily invested into the GMO, Crispr, Fake Food revolution.” dp
|
|
Rachel Parent
@RachelsNews
RT @GMOFreeUSA: The FSC must disassociate itself from any GE tree research activities and continue to clearly prohibit the commercial growi…
RT @biotechaction: #GMOs in Canada: From unlabelled to unknown. From assessed by gov regulators based on corporate data, to corporate safet…
|
|
|
Plan to Release GMO Mosquitoes in California Draws Fire From California Lawmakers, Environmentalists
As environmental advocates call on regulators to “lead with sound science” regarding the proposed release of thousands of genetically engineered (GE) mosquitoes on a weekly basis in central California, eight Democratic lawmakers on Thursday demanded that officials reject the proposal without an in-depth review of its potential impacts.
Biotech company Oxitec aims to make California the second state — after Florida — to have an experimental release of its GE mosquitoes and has applied for a permit to conduct research with its product at 48 test sites in Tulare County.
|
|
|
Record Surge of Infections in Children
|
|
Statins Double Diabetes Rates
Your risk of diabetes may even triple with long-term use.
|
|
A diesel shortage south of the border could trickle to Canada causing price spikes along with an overall rise in prices, says Dan McTeague, president of Canadians for Affordable Energy, a senior petroleum analyst for GasBuddy.com, and an 18-year veteran of the House of Commons.
A diesel supply shortage has been gripping the United States of late, with the White House declaring on Oct. 23 that reserves are down to 25 days of supply.
|
|
|
“The # 1 way for a natural retailer to compete against the mass market, is to be seen as the trusted ‘expert/advisor’ for natural foods and medicines in their community!” dp
|
|
|
Natural Help for Parkinson’s
From the Natural Path Newsletter
by Linda Woolven M.H., R.Ac & Ted Snider
\
Parkinson’s is a common disease that causes parts of the brain to deteriorate. Recent research is pointing to a safe, well known natural supplement as a possibly important part of the solution.
Parkinson’s disease is an age-related brain condition. The risk increases as you age with the average age of onset being 60. It is slightly more common in males. Parkinson’s is the second most common age-related degenerative brain diseases and the most common movement-related brain disease. It affects at least 1% of people over age 60 globally.
Parkinson’s affects the nervous system and causes tremors, stiffness and slowing of movement. Your face may become more expressionless, your arms may stop swinging when you walk and speech can become soft or slurred.
Safe help would be very welcome.
In 2020, research began to suggest that pine bark extract (Pycnogenol) could help. Pine bark is a rich source of powerful flavonoid antioxidants known as proanthocyanidins. A small study of 43 people with mild to moderate Parkinson’s were given either the drugs carbidopa/levodopa alone or with 50mg of Pycnogenol for 4 weeks.
The addition of pine bark extract led to significantly greater improvement in symptoms. Scores for cognitive function were significantly higher in the pine bark group. The pine bark also significantly lowered free radical damage. Scores for all Parkinson’s symptoms—cognitive, postural and motor—were better with the addition of pine bark extract ( J Neurosurg Sci. 2020 Jun;64(3):258-262).
Now a just published study has added to the evidence. 79 people with Parkinson’s were given either standard treatment or standard treatment plus 150mg a day of Pycnogenol for 8 weeks.
The addition of Pycnogenol led to significantly greater improvement on the Karnofsky performance scale index, a measure of functional impairment. Free radical damage and peripheral oedema both improved significantly more in the pine bark group.
Scores for Parkinson’s symptoms, including tremor, slowness of movement, rigidity, cognition and speech impairment, all improved significantly more in the pine bark group. Pine bark also led to significantly greater improvement in facial expression, including asymmetry, facial responses and altered emotional pattern ( J Neurosurg Sci. 2022 Aug ;66(4):371-377).
Taken together, these two studies begin to point to Pycnogenol as a safe supplement to improve most of the symptoms of Parkinson’s.
To Increase Your Sales by Educating Your Customers, Start Giving The Natural Path Newsletter to Your Customers Today!
The Natural Path is a natural health newsletter specifically designed to help Canadian health food stores increase their sales by educating their customers. The Natural Path contains no advertising and never mentions a brand name.
Contact Ted Snider at tedsnider@bell.net or at 416.782.8211.
For comprehensive natural help with your health, make an appointment to see Linda Woolven now. Linda’s clinic is now open for virtual appointments. Linda is a master herbalist, acupuncturist, reiki practitioner and solution-focused counsellor with a practice in Toronto.
Linda is also an artist whose paintings hang in galleries and private collections across North America. You can see some of her paintings here. |
|
| Dr. Joseph Mercola just sent a message to subscribers |
| |
| Dr. Joseph Mercola just kicked off the new Dr. Mercola's Censored Library (Private Membership) chat. Read it now in the Substack app. |
|
|
Natural Ways to Increase Autophagy and Detox Spike Proteins
After COVID Infection, Vaccination
At least 10 to 30 percent of individuals infected by SARS-CoV-2 have experienced post-COVID syndrome (also known as long-hauler syndrome, or long COVID). In the United States, 18 to 19 percent (nearly 1 in 5) of adults who reported ever having had COVID-19 currently have symptoms of long COVID, defined as symptoms lasting three or more months that were not present prior to having COVID-19.
“Post-COVID-vaccine syndrome,” a newly coined term by Dr. Paul Marik, is defined as the temporal correlation between receiving a COVID-19 vaccine and the beginning or worsening of clinical manifestations which are sufficient to diagnose a COVID-19 vaccine-induced injury when symptoms cannot be explained by other concurrent causes.
|
|
| Topic: Reducing High Blood Pressure Lowers Alzheimer’s disease Risk |
| The weekly Lifestyle Medicine Update video provides you with a quick review of a recently published study from the fields of lifestyle medicine, anti-aging, disease management and prevention, with special emphasis on breakthrough nutrition and lifestyle research that can help keep you and your family healthy and functional for as long as possible. |
|
|
|
We all know that lowering high blood pressure is an important way to reduce the risk of heart attack and stroke, but a large study completed in 2022 has shown that lowering high blood pressure in adults 69 years and older can also significantly lower the risk of developing dementia. The researchers examined the relationship between blood pressure and dementia by analyzing results from five double-blind placebo-controlled randomized trials and followed patients until the development of dementia.
|
|
A guide (pdf) published by the Memory and Aging Center of the Weill Institute for Neuroscience at the University of California San Francisco says that short-term recall and the formation of new memories are some of the functions impacted during the early stage of dementia.
Dementia is a general term for impairment of memory or cognitive skills and daily functioning, such as communicating, walking, and navigating.
According to traditional Chinese medicine, an insufficient blood supply to the brain results in degeneration and forgetfulness. Cerebral fluid stasis, chronic inflammation, and amyloidosis can deteriorate brain functions and one’s ability to remember.
|
|
|
Business News
“The best sales reps are those who stay informed, so they are considered advisors, by their customers” dp
|
|
|
Weather
“may become the biggest controversy in natural food business!” dp
|
|
|
Food
“The Fake food trend helps to further increase the importance of natural food stores!”
|
|
Tucker Carlson: The US is about to run out of diesel fuel
Watch: Frankenfoods & the End of Farming
IFF launches plant-based ingredient that mimics chunky meat texture
The company said its soy-based Supro Tex product can be hydrated with a variety of colors and flavors for use in plant-based beef, chicken, pork and lamb dishes
The current state of the meat industry
Quote from EWG.org
“Leaked corporate documents have exposed Syngenta’s attempts to cover up paraquat’s, a popular weedkiller, links to Parkinson’s disease.
Ground-breaking investigative reporting from the New Lede and the Guardian has exposed hundreds of pages of Syngenta’s internal documents. These documents prove the chemical giant has known since the 1970s that paraquat could accumulate in the brain. But they hid that information from regulators – they lied repeatedly, claiming it could not cross the blood-brain barrier. Even Syngenta’s own research showed the weedkiller could harm the brain.”
Saskatchewan Introduces Legislation Meant to Assert Provincial Jurisdiction Over Natural Resources
https://www.theepochtimes.com/saskatchewan-introduces-legislation-meant-to-assert-provincial-jurisdiction-over-natural-resources_4836280.html
|
|
| GlycoNet and Partners Invest $6.5 Million in Carbohydrate Research with One Health Focus |
|
|
This investment will support state-of-the-art glycomics research that focuses on different aspects of One Health—human, animal and environmental health.
FOR IMMEDIATE RELEASE
EDMONTON, November 3, 2022 – GlycoNet, one of the world’s leaders in glycomics research and discovery, announced a $2.46 million investment for 21 glycomics projects across Canada. Industry collaborators, health foundations and business partners are also co-investing $4 million, bringing the total funding to almost $6.5 million. This funding will support research critical to improving the health of humans, animals and the environment.
“As the study of carbohydrates, known as glycomics, continues to rapidly improve our understanding of biological systems, our research and collaboration have grown to focus on One Health, which recognizes the interconnections among people, animals, and the environment,” says Elizabeth Nanak, CEO, GlycoNet. “Our funding will further the development of made-in-Canada health solutions while building a sustainable, diverse bioeconomy, through advancing Canadian glycomics research, commercialization, and training of top talent.”
One of the funded initiatives is advancing a carbohydrate-based “cage” technology that enables anti-inflammatory drugs to be delivered more efficiently to the lower gastrointestinal tract, reducing the potential for side effects. Dr. Harry Brumer at the University of British Columbia is leading the team developing this technology, which could be used to improve the treatment of lower gut diseases such as inflammatory bowel disease—a condition that affects 300,000 Canadians (Crohn’s and Colitis Canada).
“Support from GlycoNet and other partners has been invaluable to enable us to build a diverse team of chemists, microbiologists, and clinical scientists across different provinces to accelerate technology development toward translation,” says Brumer.
Further, the announced funding will support a project set to develop a carbohydrate-based vaccine to protect pigs against the infection caused by Streptococcus suis, a common cause of severe disease and death in piglets. Dr. Mariela Segura, who is leading the project at the University of Montreal, anticipates that the vaccine will provide an alternative to the use of antimicrobials, helping combat the growing challenge of antimicrobial resistance, while also supporting the Canadian economy. Across the country, more than 7,000 pig farms contribute to the creation of tens of thousands of jobs and a resulting economic output of $23.8 billion (Canadian Pork Council).
This investment is also funding research to develop innovative biomarkers for measuring the health status of ocean food resources in the context of climate change. The research led by Dr. Yves St-Pierre at Institut national de la recherche scientifique involves integrating our knowledge of carbohydrates in biological processes to enhance the analysis of samples collected from mussels and fish.
“With climate change putting continuous pressure on marine resources, it is increasingly important that we have sensitive and predictive biomarkers to help with routine monitoring of marine resources,” says St-Pierre. “Changes in the health of ocean food sources have profound impacts in terms of food safety, as well as economical and social consequences for local fishing communities or northern communities.”
Mobilizing knowledge, expertise and collaborations in the study of carbohydrates opens new doors to understanding the relationships that underpin human, animal and environmental health. This funding will enable researchers to develop made-in-Canada One Health solutions, while also yielding the creation of new companies, jobs and economic growth.
Quick Facts
- Glycomics is the study of carbohydrates or sugars (called glycans) in all living organisms.
- Today’s announcement is for $2.46 million in funding for glycomics research plus $4 million in co-funding from research partners and industry collaborators across Canada.
- Since 2015, GlycoNet has invested $32 million from the federal Network of Centres of Excellence program and leveraged $39 million of partner funding into R&D, trained over 590 highly qualified personnel and has supported the start-up of 5 new Canadian companies.
Learn more here about the projects receiving funding.
About GlycoNet
GlycoNet is the network under which GlycoNet Integrated Services (GIS) operates. GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians using a One Health approach. GlycoNet is a pan-Canadian research network consisting of 175 researchers in 35 institutions across the country participating in 125 funded projects. GlycoNet researchers use the study of carbohydrates (sugars) in living cells to find solutions to unmet health needs through the development of drugs, vaccines and diagnostics. GlycoNet focuses on four major research areas: cancer, chronic diseases, infectious diseases, and neurodegenerative diseases. GlycoNet is also a leader in training the next generation of glycoscientists and promoting collaboration and advancement in glycomics research. Learn more on our website: glyconet.ca.
Media Contacts
Swati Mehta
Account Director, PR Associates
smehta@prassociates.com
403-804-0768 |
|
|
|
|
|
|
|
|
|
